Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: In vivo evaluation of DuP714 and Argatroban in a porcine angioplasty model and comparison to r-hirudin

Thrombosis Research

Volumn 116, Issue 6, 2005, Pages 525-532

  McBane II, Robert D ^a   Hassinger, Nancy L ^b   Mruk, Jozef S ^c   Grill, Diane E ^a   Chesebro, James H ^d  

^a MAYO CLINIC   (United States)

^b Duluth Clinic   (United States)

^c Heartland Clinic   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Coronary disease; Inhibitors; Platelets; Thrombin; Thrombosis

Indexed keywords

ACETYL DEXTRO PHENYLALANYLPROLYLBOROARGININE; ARGATROBAN; FIBRINOGEN; INDIUM 111; IODINE 125; RECOMBINANT HIRUDIN; SODIUM CHLORIDE; THROMBIN INHIBITOR;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY THROMBOSIS; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFICACY; FEMALE; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZATION; SWINE; THROMBOCYTE; THROMBUS;

ANGIOPLASTY, BALLOON; ANIMALS; ANTICOAGULANTS; BORON COMPOUNDS; DRUG EVALUATION, PRECLINICAL; HIRUDINS; OLIGOPEPTIDES; PIPECOLIC ACIDS; RECOMBINANT PROTEINS; SWINE; THROMBIN; THROMBOSIS;

EID: 24944494074     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.02.010     Document Type: Article

References (33)

1. M. Heras, J.H. Chesebro, M.W. Webster, J.S. Mruk, D.E. Grill, and W.J. Penny Hirudin, heparin and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis Circulation 82 1990 1476 1484
2. V. Toschi, R. Gallo, M. Lettino, J.T. Fallon, S.D. Gertz, and A. Fernandez-Ortiz Tissue factor modulates the thrombogenicity of human atherosclerotic plaques Circulation 95 1997 594 599
3. V. Fuster, L. Badimon, and J.J. Badimon The pathogenesis of coronary artery disease and the acute coronary syndromes N Engl J Med 326 92 1992 242 250
4. S.R. Coughlin How the protease thrombin talks to cells Proc Natl Acad Sci U S A 96 1999 11023 11027
5. M.A. Shuman Thrombin cellular interactions Ann NY Acad Sci 485 1986 349 368
6. I.J. Sarembock, S.D. Gertz, LW Gimple, R.M. Owen, E.R. Powers, and W.C. Roberts Effectiveness of recombinant desulphato-hirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits Circulation 84 1991 232 243
7. J.N. Wilcox, J. Rodriguez, R. Subramanian, J. Ollerenshaw, C. Zhong, and D.J. Hayzer Characterization of thrombin receptor expression during vascular lesion formation Circ Res 75 1994 1029 1038
8. N.A. Nelken, S.J. Soifer, J. O'Keefe, T.K. Vu, I.F. Charo, and S.R. Coughlin Thrombin receptor expression in normal and atherosclerotic human arteries J Clin Invest 90 1992 1614 1621
9. P. Zoldhelyi, J. Bichler, W.G. Owen, D.E. Grill, V. Fuster, and J.S. Mruk Persistent thrombin generation in humans during specific thrombin inhibition with hirudin Circulation 90 1994 2671 2678
10. M. Heras, J.H. Chesebro, W.J. Penny, K.R. Bailey, L. Badimon, and V. Fuster Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs: heparin versus recombinant hirudin, a specific thrombin inhibitor Circulation 79 1989 657 665
11. W. Wysokinski, R. McBane, J.H. Chesebro, and W.G. Owen Reversibility of platelet thrombosis in vivo. Quantitative analysis in porcine carotid arteries Thromb Haemost 76 1996 1108 1113
12. R.M. Knabb, C.A. Kettner, P.B. Timmermans, and T.M. Reilly In vivo characterization of a new synthetic thrombin inhibitor Thromb Haemost 67 1992 56 59
13. C. Kettner, L. Mersinger, and R. Knabb The selective inhibition of thrombin by peptides of boroarginine J Biol Chem 265 1990 18289 18297
14. A. Chiu, S. Mousa, and L. Pease Inhibition of the thrombin-platelet reactions by Dup714 Biochem Biophys Res Commun 179 1991 1500 1508
15. T.M. Reilly, R.M. Knabb, S.M. Hassell, J.M. Bozarth, M.S. Forsythe, and M.C. Mayo Effect of thrombin inhibitors on platelet functions: comparative analysis of Dup714 and hirudin Blood Coagul Fibrinolysis 3 1992 513 517
16. M.A. Hussain, R. Knabb, B.J. Aungst, and C. Kettner Anticoagulant activity of a peptide boronic acid thrombin inhibitor by various routes of administration in rats Peptides 12 1991 1153 1154
17. T. Yamashita, J. Yamamoto, Y. Sasaki, and A. Matsuoka The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels Thromb Res 69 1993 93 100
18. M.J. Winn, K. Jain, and D.D. Ku Argatroban and inhibition of the vasomotor actions of thrombin J Cardiovasc Pharm 22 1993 754 760
19. H. Kawai, T. Yamamoto, H. Hara, and Y. Tamao Inhibition of factor Xa-induced platelet aggregation by a selective thrombin inhibitor, argatroban Thromb Res 74 1994 85 91
20. H. Nishiyama, K. Umemura, A.R. Saniabadi, Y. Takiguchi, T. Uematsu, and M. Nakashima Enhancement of thrombolytic efficacy of tissue-type plasminogen activator by adjuvants in the guinea pig thrombosis model Eur J Pharm 264 1994 191 198
21. C.V. Jackson, H.C. Wilson, V.G. Growe, R.T. Shuman, and P.D. Geṡellchen Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis J Cardiovasc Pharm 21 1993 587 594
22. J. Schneider Heparin and the thrombin inhibitor argatroban enhance fibrinolysis by infused or bolus-injected saruplase (r-scu-PA) in rabbit femoral artery thrombosis Thromb Res 64 1991 677 689
23. H.K. Gold, F.W. Torres, H.D. Garabedian, W. Werner, I.K. Jang, and A. Khan Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris J Am Coll Cardiol 21 1993 1039 1047
24. I.K. Jang, D.F. Brown, R.P. Giugliano, H.V. Anderson, D. Losordo, and J.C. Nicolau A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study J Am Coll Cardiol 33 1999 1879 1885
25. J.C. Powers, and Kam Chih-Min Synthetic substrates and inhibitors of thrombin L.J. Berliner Thrombin, structure and function 1992 Plenum New York, NY 117 158
26. 2-[(3-methyl-1, 2,3,4-tetrahydro-8-quinolinyl)-sulfonyl]-l-arginyl)]-2-piperidinecarboxylic acid Biochemistry 23 1984 85 90
27. S.R. Stone, and J. Hofsteenge Kinetics of the inhibition of thrombin by hirudin Biochemistry 25 1986 4622 4628
28. J.A. Bittl, J. Strony, J.A. Brinker, W.H. Ahmed, C.R. Meckel, and B.R. Chaitman Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators N Engl J Med 333 1995 764 769
29. Anonymous A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group Eur J Heart 18 1997 1416 1425
30. Anonymous A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators N Engl J Med 336 1997 1621 1628
31. Anonymous Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators Lancet 353 1999 429 438
32. Z. Mallat, B. Hugel, J. Ohan, G. Leseche, J.M. Freyssinet, and A. Tedgui Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity Circulation 99 1999 348 353
33. P.L. Giesen, U. Rauch, B. Bohrmann, D. Kling, M. Roque, and J.T. Fallon Blood-borne tissue factor: another view of thrombosis Proc Natl Acad Sci U S A 96 1999 2311 2315